Management of Frontal Parietal Atrophy

Diagnostic Evaluation

• Brain MRI is the preferred imaging modality to confirm frontal parietal atrophy, showing characteristic patterns of cortical thinning in frontal and parietal regions 1, 2
• FDG-PET shows hypometabolism in prefrontal, frontal, and parietal regions, which can help differentiate from other neurodegenerative conditions 2, 3
• Diffusion-weighted imaging may show diffusion restriction in white matter lesions that can persist for months to years 2

Pharmacological Management

• Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) should be initiated early to provide modest improvement or stabilization of cognitive symptoms, as recommended by the American Academy of Family Physicians 4, 5
• Start donepezil at 5 mg daily, which can be increased to 10 mg daily after four weeks if tolerated, according to the American Academy of Family Physicians 5

Non-Pharmacological Interventions

• Implement personalized environmental supports tailored to the individual's cognitive profile and functional abilities, as suggested by the Alzheimer's Association 6
• Encourage regular physical activity, which has been shown to reduce the risk of cognitive decline, according to the Alzheimer's Association 6

Caregiver Support and Education

• Educate caregivers about the expected clinical course and impact on cognition and function, as recommended by the American Academy of Family Physicians and the Alzheimer's Association 4, 6
• Provide resources and support for caregivers, who are valuable allies in management and implementation of the care plan, according to the American Academy of Family Physicians 4

Disease Progression Monitoring

• Schedule regular follow-up to monitor disease progression, as imaging findings such as white matter lesions and brain atrophy typically worsen over time, as reported in the Journal of Internal Medicine 2, 7
• Adjust the management plan as the disease progresses from early to middle and advanced stages, as recommended by the American Academy of Family Physicians 4

Special Considerations

• In early-stage disease, discuss future care preferences and assist with advance care planning, as recommended by the American Academy of Family Physicians 4
• In advanced-stage disease, provide support for activities of daily living and guidance regarding placement decisions and terminal care options, according to the American Academy of Family Physicians 4